PT2097137E - Composições que compreendem estrôncio e suas utilizações no tratamento ou na prevenção de gengivite, periodontite, periodontite como manifestação de doenças sistémicas, e doenças periodontais necrosantes - Google Patents

Composições que compreendem estrôncio e suas utilizações no tratamento ou na prevenção de gengivite, periodontite, periodontite como manifestação de doenças sistémicas, e doenças periodontais necrosantes

Info

Publication number
PT2097137E
PT2097137E PT78179686T PT07817968T PT2097137E PT 2097137 E PT2097137 E PT 2097137E PT 78179686 T PT78179686 T PT 78179686T PT 07817968 T PT07817968 T PT 07817968T PT 2097137 E PT2097137 E PT 2097137E
Authority
PT
Portugal
Prior art keywords
periodontitis
diseases
gingivitis
manifestation
strontium
Prior art date
Application number
PT78179686T
Other languages
English (en)
Inventor
John Nikolaj Hvarre Christensen
Original Assignee
Mokwalo Spf S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mokwalo Spf S A filed Critical Mokwalo Spf S A
Publication of PT2097137E publication Critical patent/PT2097137E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Birds (AREA)
PT78179686T 2006-11-21 2007-11-20 Composições que compreendem estrôncio e suas utilizações no tratamento ou na prevenção de gengivite, periodontite, periodontite como manifestação de doenças sistémicas, e doenças periodontais necrosantes PT2097137E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200601522 2006-11-21

Publications (1)

Publication Number Publication Date
PT2097137E true PT2097137E (pt) 2013-01-08

Family

ID=39099797

Family Applications (1)

Application Number Title Priority Date Filing Date
PT78179686T PT2097137E (pt) 2006-11-21 2007-11-20 Composições que compreendem estrôncio e suas utilizações no tratamento ou na prevenção de gengivite, periodontite, periodontite como manifestação de doenças sistémicas, e doenças periodontais necrosantes

Country Status (7)

Country Link
US (2) US20100272802A1 (pt)
EP (1) EP2097137B1 (pt)
DK (1) DK2097137T3 (pt)
ES (1) ES2395740T3 (pt)
PL (1) PL2097137T3 (pt)
PT (1) PT2097137E (pt)
WO (1) WO2008061535A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110097372A1 (en) * 2009-10-26 2011-04-28 Rucinski Paul J Devices, methods, and compositions for controlling infections
NL2004260C2 (en) * 2010-02-18 2011-08-22 Univ Amsterdam Disinfectant composition and its use in dental treatment.
EP2530068A1 (en) 2011-05-31 2012-12-05 Lacer, S.A. New strontium salts, synthesis and use thereof in the treatment of osteoporosis
CN114028327B (zh) * 2021-12-24 2023-09-12 西岭(镇江)医疗科技有限公司 一种含依克多因和氯化锶口腔用中药抑菌凝胶及其制备、使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3988434A (en) * 1972-08-07 1976-10-26 Schole Murray L Dental preparation
US5380530A (en) * 1992-12-29 1995-01-10 Whitehill Oral Technologies Oral care composition coated gum
US5641747A (en) * 1994-07-25 1997-06-24 Temple University-Of The Commonwealth System Of Higher Education Treatment of osteopetrotic diseases
JP2001511153A (ja) * 1997-02-04 2001-08-07 ブイ． コスバブ，ジョン 血管変性性疾患の予防および処置のための組成物および方法
AUPP494798A0 (en) * 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
US20040053968A1 (en) * 2001-12-28 2004-03-18 Hartman George D. Methods and compositions for treating peridontal disease
EP1622629B1 (en) * 2003-05-07 2013-07-10 Osteologix A/S Controlled-release composition containing a strontium salt
ATE443541T1 (de) * 2004-06-25 2009-10-15 Strontin Aps Zusammensetzungen mit strontium und vitamin d und ihre verwendungen

Also Published As

Publication number Publication date
US20170157001A1 (en) 2017-06-08
EP2097137A1 (en) 2009-09-09
DK2097137T3 (da) 2013-01-14
WO2008061535A1 (en) 2008-05-29
PL2097137T3 (pl) 2013-02-28
ES2395740T8 (es) 2013-12-13
US20100272802A1 (en) 2010-10-28
EP2097137B1 (en) 2012-09-19
ES2395740T3 (es) 2013-02-14

Similar Documents

Publication Publication Date Title
IL250858B (en) A tetracycline compound, a pharmaceutical composition comprising the tetracycline compound, and the tetracycline compound or the pharmaceutical composition for treating a tetracycline responsive state
WO2007146965A3 (en) Compounds for the treatment of periodontal disease
IL228402A0 (en) Nitro-cyclic compounds, their pharmaceutical preparations and their uses
WO2006136607A3 (de) Verwendung von hydrophobin-polypeptiden sowie konjugaten aus hydrophobin-polypeptiden mit wirk- oder effektstoffen und ihre herstellung sowie deren einsatz in der kosmetik
IL200746A0 (en) Cyclopamine analog compounds, compositions comprising the same and uses thereof
IL203915A (en) Annotations of 2-Benzylphenyl-6-Hydroxymethyl-Tetrahydro-2 H-Pyrene-3,4,5-Triol
WO2009077443A3 (de) Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
HK1092722A1 (en) Pharmaceutical compositions and their use for manufacturing the medicament for treating atherosclerosis, dyslipidemias and related conditions
HK1127877A1 (en) Composition containing peptide as the active ingredient
WO2007106436A3 (en) Photoactive compounds and compositions and uses thereof
IL206395A (en) N- Heterocyclic-7-Oxo-6-Sulphoxy-6,1-Diazabicyclo [1.2.3] Octane-2-Carboxamides and Pharmaceuticals Containing Them
AU2003220240A8 (en) Boswellin compositions enhanced with 3-beta-acetyl-11-keto-beta-boswellic acid ( akba ), industrial manufacture and their uses
WO2006056696A3 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
EP2048178A4 (en) REESTRATIVE RESPONSE PRODUCT, PRODUCT CONTAINING GELIER AND COSMETIC PREPARATION THEREOF
WO2007002823A3 (en) Formulations of conjugated estrogens and bazedoxifene
WO2008001325A3 (en) Herbal compositions for the treatment of diseases of the oral cavity
WO2007003264A3 (de) Polyasparaginsäurederivate in polysiloxan-haltigen beschichtungsmitteln
WO2010046061A3 (de) Kosmetische und/oder pharmazeutische zubereitungen
WO2012075015A3 (en) Oral metronidazole pharmaceutical compositions
PL2097137T3 (pl) Kompozycje zawierające stront i ich zastosowanie w leczeniu lub zapobieganiu zapaleniu dziąseł, zapaleniu przyzębia, zapaleniu przyzębia będącemu manifestacją chorób układowych i martwiczym chorobom przyzębia
HK1111351A1 (en) Cosmetic compositions comprising specific cyclohexanmono-, -di-or-triols or cyclohexyl methan-or-ethan-or-propoanols
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
MX2007007355A (es) 5-(2,2-dimetil-ciclopropil)-3-metil-pen-2-en nitrilo como fragancia y sabor.
GB0307695D0 (en) Compounds,compositions and processes
WO2008050157A3 (en) Ozonated oil formulations